Chimerix Raises $16 Million
Chimerix Inc., a Durham, N.C.-based developer of orally-available antiviral therapeutics, has raised $16 million in Series E funding. Return backers included Canaan Partners, Alta Partners, Sanderling Ventures and Asset Management Company. Chimerix previously raised around $45 million.
11 August 2009•3 mins read
